Jason Wittes

Stock Analyst at Roth MKM

(0.79)
# 2368
Out of 5,383 analysts
63
Total ratings
Success rate
Average return
23 Stocks
Name Action PT Current % Upside Ratings Updated
SYK Stryker
Maintains: Strong Buy
405 456
394.43 15.61% 11 May 2, 2025
ALUR Allurion Technologie...
Reiterates: Buy
16 16
2.49 542.57% 2 Mar 21, 2025
MGRM Monogram Technologie...
Maintains: Strong Buy
4 6
2.87 88.15% 2 Mar 18, 2025
FBIO Fortress Biotech
Reiterates: Strong Buy
15 16
1.88 751.06% 3 Mar 11, 2025
OFIX Orthofix Medical
Reiterates: Buy
22 22
11.06 98.92% 5 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
60 72
60.54 18.93% 3 Feb 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
5.44 102.21% 2 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
100 115
58.64 96.11% 4 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
36 36
6.76 432.54% 1 Jul 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
11
7.07 55.59% 1 Jun 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
1.46 584.93% 1 Jun 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
100
82.89 20.64% 1 May 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
2.19 128.31% 4 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
1.33 576.69% 2 Feb 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
75
31.91 135.04% 2 Oct 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
10.99 100.18% 3 Oct 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
120
91.46 31.2% 7 Oct 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
206
165.59 24.4% 1 Sep 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
145
213.98 -32.24% 1 Jun 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
13.14 14.16% 2 Mar 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
200
17.13 1067.54% 3 Feb 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
42
n/a n/a 1 Jul 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
26
37.77 -31.16% 1 Feb 22, 2017